Health
Researchers at the University of Granada have developed nanoparticles of maslinic acid, a natural compound derived from olive oil production waste.
These nanoparticles exhibit remarkable potential in combating various cancers, including breast, colon, pancreatic and prostate. The team’s approach aims to enhance effectiveness and broaden the maslinic acid applications in oncology.
This is a major leap forward in the search for new therapeutic strategies that produce fewer side effects and that are more selective in the fight against these two types of cancer (breast and pancreatic).- Juan Antonio Marchal Corrales, researcher, University of Granada
Maslinic acid is a naturally occurring compound extracted from the byproducts of olive oil production. It boasts a range of significant health benefits, making it a valuable candidate for medical research.
Among its notable attributes, maslinic acid demonstrates potent antioxidant properties, shielding the body from oxidative stress and mitigating the risk of diseases associated with oxidative damage, such as cardiovascular conditions, cancer, and premature aging.
See Also:Health NewsIn addition, maslinic acid exhibits anti-inflammatory effects and is an effective antimicrobial agent against various bacteria and fungi.
This antimicrobial activity aids in combating infections and inhibiting the proliferation of harmful microorganisms within the body. However, maslinic acid’s most distinguishing feature lies in its potential to fight cancer.
Laboratory tests on cells revealed maslinic acid’s promising role as a cancer cell growth inhibitor, promoting programmed cell death (apoptosis) in multiple cancer types, including breast, colon and prostate cancer.
Maslinic acid
Maslinic acid, derived from dry olive pomace, a byproduct of olive oil production, belongs to the triterpene group known as oleananes. This bioactive compound shows promise in various aspects of health. It inhibits serine proteases crucial for HIV spread, displays anti-cancer properties against colon cells, and enhances glutamate reuptake, potentially reducing nerve cell damage. With its antioxidative effects against harmful reactive species and the ability to curb inflammation, maslinic acid may support protein synthesis, growth, and joint health. It also serves as a glycogen phosphorylase inhibitor, increasing glycogen storage in the liver.
It also impedes angiogenesis, the process by which new blood vessels nourish tumors. Due to its versatility and therapeutic potential, maslinic acid has garnered substantial interest in the medical and healthcare sectors. Nevertheless, its practical application has been limited due to its low water solubility, measuring at a mere 3.6 micrograms per liter.
The breakthrough the University of Granada researchers achieved involves engineering nanoparticles that significantly enhance maslinic acid’s solubility in aqueous solutions, surpassing one million times its original solubility.
This critical advancement enables the compound’s utilization across various fields. Moreover, these nanoparticles are designed to transport other water-insoluble drugs within them, resulting in a dual antitumor effect – a combination of the maslinic acid’s inherent properties and the potency of the encapsulated drug. This innovation holds great promise for enhancing the efficacy of cancer treatments.
The resulting nanoparticles have a size ranging between 120 and 160 nanometers, exhibit uniform dispersion and remarkable stability and retain their properties for up to six months when stored.
Cell-based assays demonstrated the cytotoxic activity of these nanoparticles against breast and pancreatic cancer cell lines, with lower toxicity observed in healthy cells (fibroblasts).
Additionally, the rapid internalization of these nanoparticles by cancer cells was observed, demonstrating their capacity to transport widely used chemotherapy drugs for pancreatic and breast cancer – paclitaxel and docetaxel, respectively.
Experiments on mice verified the nanoparticles’ non-toxic nature and suitability for intravenous and oral administration.
Notably, oral administration is preferred by patients due to its high acceptability. These nanoparticles are formulated with a polymeric shell that permits the attachment of targeting molecules, facilitating a more selective antitumor treatment, specifically targeting tumor cells while sparing healthy ones.
“We have seen that these nanoparticles, whether administered intravenously or orally, are all able to reach the different organs in the body,” said Juan Antonio Marchal Corrales, a researcher at the University of Granada and co-author of the study. “And, with proper targeting, we could target them directly to tumor cells, but not healthy cells.”
“This is a major leap forward in the search for new therapeutic strategies that produce fewer side effects and that are more selective in the fight against these two types of cancer, mainly triple-negative breast cancer and pancreatic cancer, which are cancers with a high mortality rate,” he added.
This system extends the potential applications of maslinic acid across various domains. These nanoparticles can be combined with different drugs and tailored to suit specific treatment requirements in cancer treatment. This versatility positions the nanosystem as a potent tool in the ongoing battle against cancer.
More articles on: breast cancer, cancer prevention, olive oil health
Feb. 13, 2024
The Role of Gulls in Spreading Olive Seeds Across Balearic Islands
Gulls contributed to the long-distance spread of local olive seeds, facilitating the colonization and expansion of the variety
Jan. 15, 2024
Chickens Fed Olive Oil Are More Resilient to Environmental Stressors, Study Finds
Separate research has also found that olive oil consumption improves the health of chicken meat and eggs for human consumption.
Jan. 2, 2024
Extra Virgin Olive Oil Sales in Spain Fell by 40 Percent in 2023
The soaring retail price for extra virgin olive oil has driven the vital ingredient out of the reach of many families.
Nov. 15, 2023
Trade Group Announces Olive Oil Quality Testing Initiative
Faced with low supply and high prices, the North American Olive Oil Association says it seeks to deter dishonest actors.
Sep. 7, 2023
Better Soil Management Can Save Mediterranean Olive Groves
It feels like climate change has arrived, and the olive oil industry might be first in the firing line. Luckily, we already know what to do.
Jul. 26, 2023
Mediterranean Diet Associated with Successful Aging, Study Finds
Researchers found that Greeks who followed the Mediterranean diet were healthier and more active as they aged than those who followed the diet less closely.
Mar. 6, 2024
Xylella May Not Be Responsible for Olive Tree Devastation in Puglia, Study Finds
The findings could unravel a decade of policy and understanding that Xylella fastidiosa was the leading cause of Olive Quick Decline Syndrome in Puglia.
Apr. 24, 2024
Officials Urge Croatia's Tourism Operators to Showcase Award-Winning Olive Oils
Olive growers and millers are being encouraged to showcase their products and processes to the country’s 20 million annual visitors.